ImmunoForge Co., Ltd.
PrivateLast Round
Series C
Oct 1, 2025
Est. Valuation
$75.8M
Total Funding Raised
$38.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ImmunoForge Co., Ltd. is a biotechnology company that develops therapies for treating cancer and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoForge Co., Ltd. Comparables
Compare ImmunoForge Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XL-protein | 76% | |
| Hanmi Pharm Co Ltd | 74% | |
| Sanofi | 71% |
ImmunoForge Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 1, 2025 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A Extension | Aug 1, 2020 | ||||
| Series A | Feb 1, 2019 | ||||
| Seed | Dec 1, 2017 |
ImmunoForge Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series B, Series A |
| Smilegate Investment | Series A |
| Company K Partners | Series C, Series B, Series A |
| KB Securities | Series B |
| Kiwoom Investment | Series B |
| Korea Omega Investment Corp | Series A |
| Korea Development Bank | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Raised $9.5M from Company K Partners, LB Investment, and Korea Development Bank.
- Sep 1, 2021
$19M round with participation from KB Securities and Kiwoom Investment.
Recent news
Latest coverage and updates
- receives_financingAug 24, 2026
ImmunoForge Inc. received financing of $3.58M in government funding on Aug 24th '26.
- attends_eventAug 24, 2026
ImmunoForge Inc. attends event Open Innovation contest.
ImmunoForge Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmunoForge Co., Ltd.'s valuation, stock price, and market status.
Is ImmunoForge Co., Ltd. a public or private company?
ImmunoForge Co., Ltd. is a private company.
What is the current stock price of ImmunoForge Co., Ltd.?
ImmunoForge Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is ImmunoForge Co., Ltd. worth (valuation)?
ImmunoForge Co., Ltd.'s valuation is estimated at $75.8M based on funding round data.
Can I buy ImmunoForge Co., Ltd. stock?
ImmunoForge Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmunoForge Co., Ltd.'s last funding round?
ImmunoForge Co., Ltd.'s most recent funding round was Series C on September 1, 2021.
Who are the main investors in ImmunoForge Co., Ltd.?
Key investors in ImmunoForge Co., Ltd. include BNH INVESTMENT, Smilegate Investment, Company K Partners, KB Securities, Kiwoom Investment.
Will ImmunoForge Co., Ltd. IPO soon?
No public IPO plans have been announced for ImmunoForge Co., Ltd..
How can I track ImmunoForge Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmunoForge Co., Ltd.'s secondary market activity and sign up for updates.